This paper is only available as a PDF. To read, Please Download here.
Chlorpromazine was given over prolonged periods to fifty-four patients with bronchospasm due to asthma, chronic bronchitis or emphysema. Symptomatic improvement occurred in 59 per cent. of all cases; it was most frequent in the group in which emotional factors were predominant. Side effects were few and unobtrusive.
To read this article in full you will need to make a payment
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:Subscribe to Respiratory Medicine
Already a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
- Ärztl. Wscht. 1953; 8: 1148
- Lancet. 1954; 1: 1349
Received: March 16, 1956
© 1956 Baillière, Tindall & Cox, Ltd. Published by Elsevier Inc.